Treating newly diagnosed type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.
Sep 6, 2023
1
112
Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from ...
Jun 4, 2013
0
0
Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer's disease, according to research from Cedars-Sinai investigators published in the journal Alzheimer's & Dementia. These changes correspond ...
May 19, 2023
0
57
A study led by the Cedars-Sinai Department of Neurosurgery has identified certain regions in the retina—the lining found in the back of the eye—that are more affected by Alzheimer's disease than other areas. The findings ...
Nov 17, 2020
0
288
A new research paper was published in Oncotarget, titled "G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis."
May 22, 2023
0
14
New research by academics at Royal Holloway, University of London, urges scientists that are looking to finding a cure for Alzheimer's disease to focus on the role of proteins in the brain that cause Alzheimer's disease. ...
Mar 22, 2019
0
25
Without realizing it, we all rely on emotional regulation many times a day. It's the process by which we mitigate the effect of disturbing stimuli in order to stay focused, improve our well-being and respond to demands from ...
Jun 23, 2022
0
7
A medication used to treat diabetes is able to reduce hospitalizations and cardiovascular deaths in patients with heart failure by 33 percent, suggests a recent study published in the New England Journal of Medicine.
Nov 18, 2020
0
66
After cancer and heart disease, the most common group of diseases in the U.S. are autoimmune diseases, which occur when the immune system mistakenly attacks the body's own organs, tissues and cells.
Apr 28, 2020
0
113
An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment ...
Jun 24, 2022
0
112
